News & Analysis on Clinical Trial Services & Contract Research And Development
Dispatches from CPhI
Catalent says it is contemplating expanding its Wisconsin single-use biologics facility as strong demand from SMEs and biotechs has almost filled current capacity.
US biotech Asterias Biotherapeutics will set up a UK subsidiary to access Cell Therapy Catapult’s (CTC) process development know-how.
Cel-Sci has secured a $5m fighting fund for its battle with CRO inVentiv Health Clinical LLC which it says is enough to go “the whole way.”
update
Activists from Spanish NGO Ecologistas en Acción and global consumer watchdog SumOfUs disrupted proceedings at CPhI in Madrid today.
Clients are turning their backs on low-cost economies like India and returning to Infa Group, the Italian API maker says.
Rival injectable drug contractors were felled by a stricter MHRA take on rules says Symbiosis' CEO who is confident his firm's compliance record will help it thrive.